Skip to main content

Table 5 Standardized Incidence Ratios (SIRs) for overall cancer and the 10 leading causes of cancer.

From: Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials

INCIDENCE ICD-10 Code Expected incidence Observed Incidence SIR L95%CI U95%CI
Cancers Overall C00:C99 excl. C56, C57.0, C44 4610 4131 88.1% 85.4% 90.9%
Lung Cancer C33:C34 582 328 56.2% 50.2% 62.6%
Breast Cancer C50 1715 1748 99.8% 95.1% 104.6%
Colorectal Cancer C18:C21 511 471 91.1% 83.1% 99.8%
Pancreatic Cancer C25 122 84 68.1% 54.3% 84.4%
Oesophagus Cancer C15 75 54 71.6% 53.8% 93.4%
Stomach Cancer C16 65 56 85.0% 64.0% 110.6%
N-H Lymphoma C82:C85, C96 168 175 103.6% 88.8% 120.2%
Leukaemia C91:C95 75 58 77.7% 59.0% 100.4%
Uterus Cancer C54:C55 318 293 91.1% 80.9% 102.2%
Bladder Cancer C67 77 64 79.5% 60.8% 102.1%
  1. Ovarian (C56)/tubal cancer (C57.0) and other malignant neoplasm of skin (C44) have been excluded. Average time in trial at censoring (1st June 2006) = 2.58 yrs/woman.